AAM
FPRX

Alpine Associates Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Alpine Associates Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,007,700
Closed -$75.6M – 70
2021
Q1 		$75.6M Buy
+2,007,700
New +$50.1M 2.05% 15

Alpine Associates Management's FPRX Position: Q2 2021 in Review

Alpine Associates Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 2,007,700 shares — an estimated $75.6M sold.

Alpine Associates Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $75.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Alpine Associates Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Alpine Associates Management sold 2,007,700 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $75.6M.
  • Alpine Associates Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Alpine Associates Management's Five Prime Therapeutics, Inc. position peaked at $75.6M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Alpine Associates Management's 13F filing for Q2 2021, filed 11 Aug 2021.